Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ned Lewis

Showing results (11-20 of 64) with videos related to

Pageof 7
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 28, 2019
Depletion-of-susceptibles Bias in Analyses of Intra-season Waning of Influenza Vaccine EffectivenessG Thomas Ray, Ned Lewis, Nicola P Klein, et al.
Human Vaccines & Immunotherapeutics|May 14, 2020
Identification and description of mumps cases in a non-outbreak setting and evaluation of the effectiveness of mumps-containing vaccines over timeOusseny Zerbo, Sharareh Modaressi, Julia R Glanternik, et al.
Open Forum Infectious Diseases|July 4, 2020
Safety of Recombinant Influenza Vaccine Compared to Inactivated Influenza Vaccine in Adults: An Observational StudyJohn Hansen, Kristin Goddard, Julius Timbol, et al.
Vaccine|September 12, 2012
Safety of Zostavax™--a cohort study in a managed care organizationRoger Baxter, Trung Nam Tran, John Hansen, et al.
Vaccine|July 5, 2016
Safety of DTaP-IPV/Hib vaccine administered routinely to infants and toddlersJohn Hansen, Julius Timbol, Ned Lewis, et al.
Plos One|February 27, 2020
Vaccine effectiveness of cell-culture relative to egg-based inactivated influenza vaccine during the 2017-18 influenza seasonNicola P Klein, Bruce Fireman, Kristin Goddard, et al.
Pediatrics|June 6, 2023
Safety of COVID-19 mRNA Vaccination Among Young Children in the Vaccine Safety DatalinkKristin Goddard, James G Donahue, Ned Lewis, et al.
Vaccine|April 14, 2017
Asthma exacerbations among asthmatic children receiving live attenuated versus inactivated influenza vaccinesG Thomas Ray, Ned Lewis, Kristin Goddard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 12, 2018
Intraseason Waning of Influenza Vaccine EffectivenessG Thomas Ray, Ned Lewis, Nicola P Klein, et al.
Vaccine|February 12, 2013
A postlicensure evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in children 24-59 months of ageSeth L Toback, Christopher S Ambrose, Abigail Eaton, et al.
Pageof 7

Showing results (11-20 of 64) with videos related to

Sort By:
Pageof 7
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 28, 2019
Depletion-of-susceptibles Bias in Analyses of Intra-season Waning of Influenza Vaccine EffectivenessG Thomas Ray, Ned Lewis, Nicola P Klein, et al.
Human Vaccines & Immunotherapeutics|May 14, 2020
Identification and description of mumps cases in a non-outbreak setting and evaluation of the effectiveness of mumps-containing vaccines over timeOusseny Zerbo, Sharareh Modaressi, Julia R Glanternik, et al.
Open Forum Infectious Diseases|July 4, 2020
Safety of Recombinant Influenza Vaccine Compared to Inactivated Influenza Vaccine in Adults: An Observational StudyJohn Hansen, Kristin Goddard, Julius Timbol, et al.
Vaccine|September 12, 2012
Safety of Zostavax™--a cohort study in a managed care organizationRoger Baxter, Trung Nam Tran, John Hansen, et al.
Vaccine|July 5, 2016
Safety of DTaP-IPV/Hib vaccine administered routinely to infants and toddlersJohn Hansen, Julius Timbol, Ned Lewis, et al.
Plos One|February 27, 2020
Vaccine effectiveness of cell-culture relative to egg-based inactivated influenza vaccine during the 2017-18 influenza seasonNicola P Klein, Bruce Fireman, Kristin Goddard, et al.
Pediatrics|June 6, 2023
Safety of COVID-19 mRNA Vaccination Among Young Children in the Vaccine Safety DatalinkKristin Goddard, James G Donahue, Ned Lewis, et al.
Vaccine|April 14, 2017
Asthma exacerbations among asthmatic children receiving live attenuated versus inactivated influenza vaccinesG Thomas Ray, Ned Lewis, Kristin Goddard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 12, 2018
Intraseason Waning of Influenza Vaccine EffectivenessG Thomas Ray, Ned Lewis, Nicola P Klein, et al.
Vaccine|February 12, 2013
A postlicensure evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in children 24-59 months of ageSeth L Toback, Christopher S Ambrose, Abigail Eaton, et al.
Pageof 7